Trial intelligence / Profile preview

Prozac Discontinuation Study in Major Depression

NCT00427128Phase 4Completed

Sponsor
New York State Psychiatric Institute
Start
Nov 1995
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of fluoxetine in major depressive disorder (MDD), sponsored by New York State Psychiatric Institute. Started Nov 1995; status: completed.

02

Drugs

fluoxetine
03

Conditions

major depressive disorder (MDD)

Beyond the preview

Go deeper on NCT00427128.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00427128.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call